ИИ Медтех

Искусственный интеллект в здравоохранении для клиник врачей и пациентов

  • Artificial intelligence-driven circRNA vaccine development: multimodal collaborative optimization and a new paradigm for biomedical applications

    Brief Bioinform. 2025 May 1;26(3):bbaf263. doi: 10.1093/bib/bbaf263. ABSTRACT Circular RNA (circRNA) vaccines have emerged as a groundbreaking innovation in infectious disease prevention and cancer immunotherapy, offering superior stability and reduced immunogenicity compared to conventional linear messenger RNA (mRNA) vaccines. While linear mRNA vaccines are prone to degradation and can trigger strong innate immune responses, covalently closed circRNA vaccines leverage their unique circular structure to enhance molecular stability and minimize innate immune activation, positioning them as a next-generation platform for vaccine development. Artificial intelligence (AI) is revolutionizing circRNA vaccine design and optimization. Deep learning models, such as convolutional neural networks (CNNs)… ➡️➡️➡️

  • A pilot study for self-guided, active robotic training of proprioception of the upper limb in chronic stroke

    J Neuroeng Rehabil. 2025 Jun 7;22(1):130. doi: 10.1186/s12984-025-01660-6. ABSTRACT BACKGROUND: Proprioceptive impairments of the upper limb are common after stroke. These impairments are not typically addressed during assessment or rehabilitation. Currently, most robotic paradigms for training of the upper limb have focused solely on improving motor function or have targeted proprioception in individuals with combined use of visual feedback. Our goal was to design a training paradigm that directly targets proprioception of the upper limb, while minimizing reliance on other sensory information to improve sensorimotor function after stroke. METHODS: In this pilot study, 5 individuals with stroke and 5 age-matched… ➡️➡️➡️

  • High-throughput robotic isolation of human iPS cell clones reveals frequent homozygous induction of identical genetic manipulations by CRISPR-Cas9

    Stem Cell Res Ther. 2025 Jun 7;16(1):295. doi: 10.1186/s13287-025-04414-2. ABSTRACT BACKGROUND: Genome editing in human iPS cells is a powerful approach in regenerative medicine. CRISPR-Cas9 is the most common genome editing tool, but it often induces byproduct insertions and deletions in addition to the desired edits. Therefore, genome editing of iPS cells produces diverse genotypes. Existing assays mostly analyze genome editing results in cell populations, but not in single cells. However, systematic profiling of genome editing outcomes in single iPS cells was lacking. Due to the high mortality of human iPS cells as isolated single cells, it has been difficult… ➡️➡️➡️